106 related articles for article (PubMed ID: 20305606)
1. Hyperprolactinaemia - a risperidone side-effect.
Grahovac T; Ruzić K; Medved P; Pavesić-Radonja A; Dadić-Hero E
Psychiatr Danub; 2010 Mar; 22(1):120-2. PubMed ID: 20305606
[TBL] [Abstract][Full Text] [Related]
2. Risperidone-induced symptomatic hyperprolactinaemia in adolescents.
Holzer L; Eap CB
J Clin Psychopharmacol; 2006 Apr; 26(2):167-71. PubMed ID: 16633146
[TBL] [Abstract][Full Text] [Related]
3. Galactorrhea - side effect of risperidone in combination with depakine chrono in a patient with bipolar disorder.
Peitl MV; Peitl V; Grahovac T; Pavlović E
Psychiatr Danub; 2010 Mar; 22(1):125-7. PubMed ID: 20305608
[TBL] [Abstract][Full Text] [Related]
4. Low-dose risperidone augmentation of antidepressants or anxiolytics is associated with hyperprolactinemia.
Kopecek M; Bares M; Horacek J; Mohr P
Neuro Endocrinol Lett; 2006 Dec; 27(6):803-6. PubMed ID: 17187006
[TBL] [Abstract][Full Text] [Related]
5. Risperidone-induced hyperprolactinemia in adolescents: A case series.
Madhusoodanan S; Moise D
J Clin Psychiatry; 2006 Jul; 67(7):1110-3. PubMed ID: 16889455
[TBL] [Abstract][Full Text] [Related]
6. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia.
Keller R; Mongini F
Neurol Sci; 2002 Dec; 23(5):233-5. PubMed ID: 12522680
[TBL] [Abstract][Full Text] [Related]
7. Venlafaxine - quetiapine combination in the treatment of complicated clinical picture of enduring personality changes following PTSD in comorbidity with psychotic depression.
Presecki P; Mihanović M; Silić A; Vuina AL; Caratan S
Psychiatr Danub; 2010 Jun; 22(2):360-2. PubMed ID: 20562783
[TBL] [Abstract][Full Text] [Related]
8. Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone.
Segal M; Avital A; Derevenski A; Berstein S; Sandbank S; Weizman A
Int Clin Psychopharmacol; 2007 Jul; 22(4):192-6. PubMed ID: 17519641
[TBL] [Abstract][Full Text] [Related]
9. [Paroxetine augmentation with risperidone in therapy-resistant depression].
Knopf U; Hubrich-Ungureanu P; Thome J
Psychiatr Prax; 2001 Nov; 28(8):405-6. PubMed ID: 11721229
[TBL] [Abstract][Full Text] [Related]
10. Changes in prolactin levels and sexual function in young psychotic patients after switching from long-acting injectable risperidone to paliperidone palmitate.
Montalvo I; Ortega L; López X; Solé M; Monseny R; Franch J; Vilella E; Labad J
Int Clin Psychopharmacol; 2013 Jan; 28(1):46-9. PubMed ID: 23232756
[TBL] [Abstract][Full Text] [Related]
11. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
12. Side-effects of generic.
Ruzić K; Medved P; Dadić-Hero E; Graovac M; Tatalović-Vorkapić S; Grzeta IR
Psychiatr Danub; 2010 Mar; 22(1):99-101. PubMed ID: 20305600
[TBL] [Abstract][Full Text] [Related]
13. Amenorrhoea - consequence of combined treatment with sulpiride and risperidone in a patient suffering from schizophrenia.
Peitl MV; Pavlović E; Peitl A; Peitl V
Psychiatr Danub; 2010 Mar; 22(1):123-4. PubMed ID: 20305607
[TBL] [Abstract][Full Text] [Related]
14. Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis.
Cookson J; Hodgson R; Wildgust HJ
J Psychopharmacol; 2012 May; 26(5 Suppl):42-51. PubMed ID: 22472310
[TBL] [Abstract][Full Text] [Related]
15. Significant elevations of prolactin levels in patients who shifted from conventional depot antipsychotics to long-acting risperidone.
Lai YC; Chiou CC; Chen CH; Huang MC
J Clin Psychopharmacol; 2007 Oct; 27(5):523-4. PubMed ID: 17873693
[No Abstract] [Full Text] [Related]
16. The disparity of pharmacokinetics and prolactin study for risperidone long-acting injection.
Peng PW; Huang MC; Tsai CJ; Pan CH; Chen CC; Chiu CC
J Clin Psychopharmacol; 2008 Dec; 28(6):726-7; author reply 727-8. PubMed ID: 19011459
[No Abstract] [Full Text] [Related]
17. Categorical prevalence and severity of hyperprolactinaemia in two UK cohorts of patients with severe mental illness during treatment with antipsychotics.
Bushe C; Yeomans D; Floyd T; Smith SM
J Psychopharmacol; 2008 Mar; 22(2 Suppl):56-62. PubMed ID: 18477621
[TBL] [Abstract][Full Text] [Related]
18. Switching among antipsychotics--focus on side effects.
Ružić K; Dadić-Hero E; Grahovac T; Sabljić V; Kosec T; Knez R
Psychiatr Danub; 2011 Mar; 23(1):89-91. PubMed ID: 21448105
[TBL] [Abstract][Full Text] [Related]
19. [Ziprasidone-augmentation of clozapine].
Zink M; Mase E; Dressing H
Psychiatr Prax; 2004 Jul; 31(5):259-61. PubMed ID: 15243877
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics.
Bushe C; Shaw M
J Psychopharmacol; 2007 Sep; 21(7):768-73. PubMed ID: 17606473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
